FDA clears the first smartphone app to program insulin pump doses

Tandem Diabetes Care says the Food and Drug Administration (FDA) has cleared its smartphone app to program and cancel insulin doses from the t:slim X2 insulin pump. The company claims it's the first time the FDA has cleared a phone app for such a purpose.

The t:connect mobile app on iOS and Android will enable users to program and cancel bolus insulin doses from the pump, according to Tandem Diabetes Care. When connected to the pump, the app can display information about the last 24 hours of a user's glucose trends, changes in status (including alerts and alarms) and insulin therapy data.

Pumps typically require users to dial in insulin doses manually. Given that they are often able to view glucose readings on their handset, patients will be able to use their phone to determine how much insulin they need and then program their dose.

The FDA clearance could be a step toward a more convenient way for diabetes patients to administer insulin doses. Tandem Diabetes Care plans to offer the feature at no extra cost to new and in-warranty t:slim X2 insulin pump customers via a software update. The plan is to grant access to a limited number of users in the spring ahead of a broader rollout this summer.

All-in-one diabetes devices could take the hassle out of insulin injections

People with diabetes have more than a few hassles, particularly at meals. They not only have to measure their blood glucose levels and inject the right amount of insulin, but carry all the relevant equipment with them. MIT and Brigham and Women's Hospital researchers might soon eliminate many of the headaches, though. They're developing all-in-one devices (not pictured) that measure glucose, calculate the necessary insulin dose and inject you accordingly.

The first device includes the blood-drawing lancet, glucose test strips and an insulin needle. Users would first take a photo of their meal using a smartphone app to estimate the food volume and carbohydrate levels. After that, they'd start the automated process of collecting blood, calculating glucose (again through the app) and delivering the appropriate amount of insulin.

The second gadget would only need one needle jab — it would build the glucose sensor into the insulin needle and inject the appropriate amount of insulin. You'd have to wait five to ten seconds, but you wouldn't have to stick yourself twice.

The technology is still some ways off. While the first device would use parts that were already FDA-approved, it hasn't been tested in humans. The second, meanwhile, uses a new sensor type that will likely require more work to be testable with humans. Scientists have filed patents for both devices and are hoping to work with companies on further development.

There's a strong motivation to bring these devices to market, at least. People with diabetes would only need to use one device at meals, and with the hybrid sensor/needle might suffer less pain. That, in turn, could encourage consistent treatment that improves your overall wellbeing.

All-in-one diabetes devices could take the hassle out of insulin injections

People with diabetes have more than a few hassles, particularly at meals. They not only have to measure their blood glucose levels and inject the right amount of insulin, but carry all the relevant equipment with them. MIT and Brigham and Women's Hospital researchers might soon eliminate many of the headaches, though. They're developing all-in-one devices (not pictured) that measure glucose, calculate the necessary insulin dose and inject you accordingly.

The first device includes the blood-drawing lancet, glucose test strips and an insulin needle. Users would first take a photo of their meal using a smartphone app to estimate the food volume and carbohydrate levels. After that, they'd start the automated process of collecting blood, calculating glucose (again through the app) and delivering the appropriate amount of insulin.

The second gadget would only need one needle jab — it would build the glucose sensor into the insulin needle and inject the appropriate amount of insulin. You'd have to wait five to ten seconds, but you wouldn't have to stick yourself twice.

The technology is still some ways off. While the first device would use parts that were already FDA-approved, it hasn't been tested in humans. The second, meanwhile, uses a new sensor type that will likely require more work to be testable with humans. Scientists have filed patents for both devices and are hoping to work with companies on further development.

There's a strong motivation to bring these devices to market, at least. People with diabetes would only need to use one device at meals, and with the hybrid sensor/needle might suffer less pain. That, in turn, could encourage consistent treatment that improves your overall wellbeing.

This earring helps diabetics read their blood sugar levels without the pin-prick

Revolutionizing how Type 1 Diabetics monitor their blood glucose levels, the Sense Glucose Earring is an innovative non-invasive wearable that incorporates reads blood-sugar levels in the ear-lobe using safe, high-frequency radio waves.

The earring requires just a single lobe piercing (as opposed to the daily pin-prick tests that diabetes patients have to take) and sits on the ear at all times. When you need to read your blood-sugar levels, the earring uses sensors and algorithms to collect data, which is then sent to your smartphone. This massively reduces medical waste, while offering a pain-free solution for checking your sugar levels. At the same time, it turns a medical apparatus into a fashion wearable, removing the social stigma of having to carry clinical-looking blood glucose meters around with them. Instead, the Sense Glucose Earring is fashionable, safe, environment-friendly, and pain-free!

Designer: Tyra Kozlow

By looking more ‘fashionable’, this insulin injection helps break stereotypes

Spectacles, walking sticks, both are products that started as medical devices but slowly evolved into objects of fashion and style. You see, somewhere down the line people with walking difficulties and weak eyesight felt that their affliction shouldn’t make them look inferior. Thus, the stylish monocle and the fashionable walking cane were born. Youtrust brings that very approach to insulin injections.

Injections are inherently scary looking, and the fact that you’ve got to get approximately 3 of them a day doesn’t help soothe the pain, metaphorically speaking. Youtrust reinvents how they look by overhauling their clinical design for something that’s functional yet also trendy. Its form language is simple and sophisticated, and is upgraded by gradients, vibrant hues, and speckled CMF (although orange speckles on injections may irk some folks).

The Youtrust Insulin Injector comes with a concealed needle (like the ones found in blood sugar monitors). The vial sits inside the device, with a meter letting you know how much insulin is inside. You can calibrate your insulin units using the knob on the top, and a digital display on the side helps you track your daily and monthly doses as well as see step-by-step instructions for administering them (just in case someone else has to help you out). The Youtrust device comes with a pod-shaped flat design with rounded edges, which makes it easy to carry around in a bag or your pocket. Ever so often (a couple of months, maybe), its display and electronics will need charging too, and a nifty wireless charging tray lets you charge your injection by simply placing it on the tray’s surface overnight!

Now if only someone went back 20 years and made braces look cool too…

Designer: Dorian Famin

Startup claims its new wearable can monitor blood sugar without needles

A Japanese startup at CES is claiming to have solved one of the biggest problems in medical technology: Noninvasive continuous glucose monitoring. Quantum Operation Inc, exhibiting at the virtual show, says that its prototype wearable can accurately...

Telehealth got a huge boost from COVID-19. Now what?

During the height of the coronavirus pandemic, venturing outside in New York felt like preparing for battle. Germs were invisible bullets from which we tried to shield ourselves using masks and distancing. Staying home was of course the safest course...